The Hyperlipidemia market was valued at USD 18.97 Billion in 2021 and is expected to reach USD 23.84 Billion by 2029, growing at a CAGR of 2.9% (2021-2029). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.